Dr Reddy’s launches generic dementia drug in US

23 Sep 2011 Evaluate

Dr Reddy’s Laboratories Ltd has launched Rivastigmine Tartrate capsules in the US market. The capsules are a bioequivalent generic version of Exelon capsules (of Novartis Pharmaceuticals Corporation) in the US market. They are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. The Exelon brand and generic rivastigmine tartrate had U.S. sales of approximately $92.6 million for the most recent twelve months ending June 2011.

Dr. Reddys Lab Share Price

1235.15 18.00 (1.48%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×